pilot study [Design Issues]

posted by ioanam – Romania, 2006-12-22 10:29 (7114 d 08:11 ago) – Posting: # 414
Views: 7,022

Dear Sir,
I have to perform a 3 way cross over pilot study.
The test product is available in 4 strengths (e.q. 250, 500, 750 and 1000 mg) with dose proportionality between these strengths. The pharmacokinetics is not influenced by food.
Is a good design for this study a 3 way crossover study in fasted conditions with 3 sequences, 3 treatments and 3 periods with:
Test A – test product 4 x 250 mg
Test B – test product 1000 mg
Reference – reference (1000 mg)?
Thank you
and Marry Christmas!

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
110 visitors (0 registered, 110 guests [including 18 identified bots]).
Forum time: 19:41 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5